JAPAY changes

Pick any two versions below to diff them.

FromTo

View the full Nov 10, 2026 version

Price: $15.21
Discount category: Close to intrinsic value
Intrinsic value source: AI estimate
Next earnings: 2027-02-12
Next earnings is estimate: Yes
Company name: Japan Tobacco
Sector: Tobacco
About: Japan Tobacco (JT) makes and sells cigarettes and other tobacco products in Japan and in many other countries, and it has a processed food business in Japan. Its Global Flagship Brands are Winston, Camel, MEVIUS and LD. Its reduced-risk products include the Ploom heated tobacco devices and sticks. The tobacco business reports three clusters. Asia includes Japan, the Philippines and Taiwan. Western Europe includes Italy, the United Kingdom and Spain. EMA includes Turkey, the United States, Romania and Russia. In the first nine months of 2026, EMA gave ¥476.3 billion of the ¥1,005.4 billion of adjusted operating profit of the tobacco business. In 2025, JT transferred its pharmaceutical business to Shionogi and sold its shares of Torii Pharmaceutical. The company reports in yen under IFRS, and its shares trade on the Prime market of the Tokyo Stock Exchange. JAPAY is an ADR in the United States, and one ADS represents one half of one JT share. Takehiko Tsutsui is its president.
Thesis: Japan Tobacco trades close to the AI estimate because investors weigh strong pricing and Ploom growth against the possible loss of its Russian business. On November 5, 2026, a Russian presidential decree placed four of the group's Russian manufacturing companies under temporary management. JT says that it is checking the details and cannot yet estimate the effect, and it does not give the profit of the Russian business. Before the decree, the business was strong: in the first nine months of 2026, adjusted operating profit rose 21.6% to ¥972.4 billion, and JT raised its 2026 forecast to profit of ¥662.0 billion and a dividend of ¥272 per share. For the price to be earned, three things must be true. The loss of profit from Russia must stay limited, or JT must keep some value from the business. Pricing and Ploom growth in the other markets must keep adjusted operating profit growth near the high single digit target of Business Plan 2026. The yen and tobacco taxes must not cut profit in yen. News on the Russian business and the full-year 2026 results, expected in mid-February 2027, are the next tests.
Valuation: The intrinsic value for Japan Tobacco is an AI estimate from November 10, 2026. It is not an analyst's value. An AI research agent calculated it from JT's filings. The company reports in yen, and the estimate is in U.S. dollars per ADS. The method is a multiple of earnings per share for 2027. The consolidated financial results for the nine months ended September 30, 2026 (October 29, 2026) give basic EPS of ¥348.60 for the nine months and a revised forecast of profit of ¥662.0 billion and basic EPS of ¥372.88 for 2026. They give 2,000,000,000 shares issued and 224,570,251 treasury shares at September 30, 2026, bonds and borrowings of ¥1,673.4 billion and cash of ¥887.3 billion. A notice of November 6, 2026 says that a Russian presidential decree of November 5, 2026 placed four of the group's Russian manufacturing companies under temporary management, and that JT is still checking the effect. The filings do not give the profit of the Russian business, so its share of earnings is an assumption. The Form F-6 of JPMorgan Chase Bank, N.A. as depositary (October 4, 2021) states that one ADS represents one half of one share, and the ADS price of $23.62 and the Tokyo price of ¥7,383 on November 4, 2026 are close to this ratio. EPS already includes the interest on debt, so the estimate makes no debt adjustment. It uses an exchange rate of ¥158.29 per U.S. dollar, the market rate on November 9, 2026, as an assumption. The EPS and the multiples in each case are assumptions. The low case assumes that JT loses all profit from Russia and records more costs, with EPS of ¥290 for 2027, at 12 times. It gives ¥3,480 per share and $10.99 per ADS. The base case assumes that JT loses the Russian profit but grows in the other markets, with EPS of ¥330, at 14 times. It gives ¥4,620 per share and $14.59 per ADS. The high case assumes that JT keeps the Russian business, with EPS of ¥400, at 16 times. It gives ¥6,400 per share and $20.22 per ADS. The estimate assumes weights of 25%, 50% and 25%. The weighted intrinsic value is ¥4,780 per share and $15.10 per ADS. The value moves with the yen. Intangible assets are the main source of the advantage. Brands such as Winston, Camel, MEVIUS and LD, and strict rules on tobacco marketing, make it hard for new competitors to win customers, and price increases raised tobacco profit in many markets in 2026. But total demand for cigarettes falls in many markets, governments raise taxes, and the Russian decree shows that JT can lose a large business. The estimate expects the advantage to last 10 years or more, but not 20 years. As of 2026-11-10.
Risks: A Russian presidential decree of November 5, 2026 placed four of the group's Russian manufacturing companies under temporary management. JT can lose the profit of the Russian business and record losses on its assets there, and it cannot yet estimate the effect. Total demand for cigarettes falls in many markets, such as Japan, Russia and the United Kingdom. Combustibles volume fell 1.0% in the first nine months of 2026, and profit growth depends on price increases. Governments can raise tobacco taxes and add rules on products, packs and marketing. Japan raised the tax on heated tobacco in 2026. Most profit is earned in other currencies than the yen, and some markets have very high inflation. A strong yen lowers profit in yen, and the ADS price also moves with the yen. The Canadian subsidiary JTI-Macdonald pays amounts each year under a settlement of smoking and health lawsuits. Other lawsuits can bring new costs.
Balance sheet: Cash: ¥887.3B Debt: ¥1,673.4B Net debt: ¥786.1B Interest cover: 7.7× Debt due within 12 months: ¥147.8B JT funds itself with bonds, borrowings, commercial paper and cash flow. At September 30, 2026, bonds and borrowings were ¥1,673.4 billion: ¥147.8 billion current and ¥1,525.6 billion non-current. Cash and cash equivalents were ¥887.3 billion. In the first nine months of 2026, JT issued commercial paper and redeemed bonds, and operating cash flow was ¥731.2 billion, against ¥287.0 billion a year earlier. Interest cover is operating profit divided by finance costs for the first nine months of 2026 (¥947.7 billion against ¥123.1 billion), and finance costs include items other than interest. Equity attributable to owners of the parent was ¥4,120.9 billion. The 2026 dividend forecast is ¥272 per share, and JT paid ¥136 at the half year. There were 2,000,000,000 shares issued and 224,570,251 treasury shares at September 30, 2026. As of 2026-09-30.
Checkpoints: Oct 29, 2026: Q3 2026 results and 2026 forecast. Passed. Watch: Profit growth and a higher 2026 forecast pass; a lower forecast fails. Outcome: Adjusted operating profit rose 21.6% in the first nine months, and JT raised its 2026 forecast for profit to ¥662.0 billion. Dec 2026 (estimate): Effect of the Russian decree. Pending. Watch: A limited loss of profit, or a sale that keeps some value, passes; a full loss with large write-downs fails. Feb 12, 2027 (estimate): Full-year 2026 results and 2027 forecast. Pending. Watch: A 2027 forecast with profit growth outside Russia and a stable dividend passes; a lower dividend fails.
Recent events: 2026-11-06: JT announced that a Russian presidential decree, signed on November 5, 2026, placed four of the group's Russian manufacturing companies under temporary management. JT said that it was checking the details, its options and the effect on the group. Before the decree, JT had said that it was studying options for the Russian tobacco business, including a separation from the group. 2026-10-29: JT reported results for the first nine months of 2026. Revenue rose 13.6% to ¥2,991.4 billion, operating profit rose 24.2% to ¥947.7 billion and profit attributable to owners of the parent rose 20.9% to ¥618.9 billion, or ¥348.60 per share. RRP volume rose 31.1% to 13.2 billion sticks. JT raised its 2026 forecast to revenue of ¥3,903.0 billion, adjusted operating profit of ¥1,079.0 billion and profit of ¥662.0 billion. It lowered its free cash flow forecast by ¥55.0 billion to ¥596.0 billion, mainly for the purchase of fine-cut tobacco brands from Scandinavian Tobacco Group. 2026-02-12: JT announced Business Plan 2026 for the years 2026 to 2028. It expects adjusted operating profit at constant currency to grow at a high single digit rate each year. The dividend for 2025 was ¥234 per share.